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Innate immunity represents a first line of resis-
tance against pathogens and is a key determi-
nant of the activation and orientation of adaptive 
immunity. Innate immunity is also responsible 
for the activation of the inflammatory and repara-
tive responses in sterile tissue injury (Medzhitov, 
2008). The innate immune system includes a 
cellular and a humoral arm (Medzhitov, 2008; 
Bottazzi et al., 2010). Humoral fluid phase pat-
tern recognition molecules (PRMs) are diverse 
and include components of the complement cas-
cade, ficolins, collectins, and pentraxins (Holmskov 
et al., 2003; Pepys and Hirschfield, 2003; Bottazzi 
et al., 2010).
The long pentraxin 3 (PTX3) is a proto-
typic fluid-phase humoral PRM that acts as an 
essential component of the humoral arm of innate 
immunity (Garlanda et al., 2002; Bottazzi et al., 
2010; Cunha et al., 2014). PTX3 is an octameric 
glycoprotein made of a C-terminal pentraxin-
like domain and of an unrelated N-terminal do-
main, rapidly produced by myelomonocytic and 
stromal cells, including endothelial cells, fibro-
blasts, and smooth muscle cells, in response to 
primary proinflammatory cytokines, in particular 
IL-1, or TLRs, or rapidly released by neutro-
phils (Jaillon et al., 2007; Bottazzi et al., 2010). 
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Pentraxin 3 (PTX3) is a fluid-phase pattern recognition molecule and a key component of 
the humoral arm of innate immunity. In four different models of tissue damage in mice, 
PTX3 deficiency was associated with increased fibrin deposition and persistence, and thicker 
clots, followed by increased collagen deposition, when compared with controls. Ptx3-
deficient macrophages showed defective pericellular fibrinolysis in vitro. PTX3-bound 
fibrinogen/fibrin and plasminogen at acidic pH and increased plasmin-mediated fibrinolysis. 
The second exon-encoded N-terminal domain of PTX3 recapitulated the activity of the 
intact molecule. Thus, a prototypic component of humoral innate immunity, PTX3, plays a 
nonredundant role in the orchestration of tissue repair and remodeling. Tissue acidification 
resulting from metabolic adaptation during tissue repair sets PTX3 in a tissue remodeling 
and repair mode, suggesting that matrix and microbial recognition are common, ancestral 
features of the humoral arm of innate immunity.
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906 Orchestration of tissue repair by PTX3 | Doni et al.
Figure 1. PTX3 is induced after skin wounding. A skin punch wound was generated on the back of mice. PTX3 mRNA expression was assessed by 
RT-PCR (A) and PTX3 local content and plasma levels (B) were measured after wounding in mice. (A) One representative experiment in triplicate (n = 3 
independent mice/group) out of 2 is shown. (B) n = 9–11 independent mice. (C) Localization of PTX3 after skin wounding was assessed by confocal micros-
copy. Representative images are shown (n = 39 mice). C, clot; p, perilesion area; wb, wound bed; s, scab; n, neo-formed tissue. The analysis was performed 
at day 2, 7, and 14 after wounding. Bars, 100 µm. (D) Magnification images (40×) of PTX3 localization shown in C (10×) for clot (left) and damaged dermis 
(middle and right) 2 d after wounding. C, clot; wb, wound bed; e, epithelial outgrowth. Arrowheads denote cells invading the damaged dermis (middle) 
and the clot (right); dashed arrows show directionality of invading cells. Bar, 10 µm. (E–G) Cell populations (UPA+ [E], UPAR+ [F], PDGFR+, and CD68+  
[G] cells) associated with PTX3 staining (green) were assessed by confocal microscopy (day 2 after wounding). Representative merged images (left) and  
indicated cell markers (red or cyan for PDGFR) with nucleus (blue; right) are shown. Dashed arrows show directionality of invading cells directed toward 
the wound bed. Bars, 10 µm. (E and F) n = 6 mice; (G) n = 11 mice. (H) Flow cytometry analysis of intracellular and membrane staining of PTX3 in leuko-
cyte and stromal cell populations at 2 and 7 d after wounding of Ptx3+/+ and Ptx3/ mice. P1, CD45+CD11b+Ly6G+; P2, CD45+CD11b+ Ly6C+ F4/80; P3, 
CD45+CD11bCD3+; P4, CD45PDGFR+; P5, CD45PDGFR+FAP+; P6, CD45-SMA+; P7, CD45C31+. Values are expressed as relative percentage of MFI ± SD 
of Ptx3+/+ cells (filled bars) compared with Ptx3/ cells (open bars) used as a negative control. Data referring to P3 on day 2 after injury are not 
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expression was associated with bundles of remodeling cells 
that collectively invaded the wound site, including urokinase 
plasminogen activator (uPA) positive (Fig. 1 E) and uPA recep-
tor (uPAR) positive (Fig. 1 F) cells, CD68+ macrophage-like 
cells and platelet-derived growth factor receptor (PDGFR)+ 
fibroblasts and/or mesenchymal cells (Fig. 1 G). On day 2, 
PTX3 was detected by flow cytometry in neutrophils (CD11b+ 
Ly6G+), macrophages (CD11b+Ly6C+F4/80+), and stromal 
cells, in particular PDGFR+ mesenchymal cells, PDGFR+/
fibroblast activation protein+ (FAP+) reactive fibroblasts, and 
-smooth muscle actin+ (SMA+) smooth muscle cells or myo-
fibroblasts, and at low level in vascular endothelium (CD31+; 
Fig. 1 H and Fig. S1). Expression of PTX3 was confirmed at 
the level of mRNA transcripts in sorted macrophages and 
mesenchymal cells (Fig. 1 I), but not in neutrophils that store 
preformed PTX3 in granules (Jaillon et al., 2007). On day 7, 
PTX3 was detected in PDGFR+ and PDGFR+FAP+ mes-
enchymal stromal cells but not in leukocytes (Fig. 1 H). Neu-
trophils, macrophages, and PDGFR+ mesenchymal cells also 
had PTX3 associated on the cell membrane in the course of the 
skin repair (Fig. 1 H), although, as shown by confocal images 
(Fig. 1, D–G), PTX3 was mainly associated with the pericel-
lular matrix. Indeed, PTX3 is generally rapidly released from 
the cells, in particular by neutrophils (Jaillon et al., 2007).
TLRs and IL-1 are potent inducers of PTX3 and are in-
volved in the orchestration of tissue repair (Medzhitov, 2008; 
Dinarello, 2009). It was therefore important to assess the 
pathways upstream of PTX3 in skin wound healing. Induc-
tion of PTX3 was almost completely abolished in blood and 
at the wound site in MyD88-deficient mice, whereas a par-
tial reduction was observed in Il1r/, Tlr3/, Irf3/, and 
Ticam1/ mice (Fig. 1, J and K). These results suggest that 
induction of PTX3 is downstream of TLR sensing and IL-1 
amplification, with the contribution of both MyD88- and 
TRIF-dependent pathways.
Early grossly evident acceleration of reduction of wound 
area was observed in Ptx3/ mice (Fig. 2, A and B). Histo-
logical analysis revealed that Ptx3/ mice had significantly 
thicker clots compared with controls (138.58 ± 25.8 µm and 
78.59 ± 28.25 µm, in Ptx3/ and WT mice, respectively; 
P = 0.0001; n = 8) on day 2, and thicker scabs (1,112.08 ± 
189.13 µm compared with 645.09 ± 87.16 µm in WT mice; 
P = 0.044; n = 8) on day 7, characterized by excessive accu-
mulation of eosinophilic material (Fig. 2 C) and fibrin (Fig. 2, 
D and E) throughout the observation time. In addition, an 
augmented content of factors (CD62P, TGF, PDGF, sero-
tonin, CXCL1, and CXCL2) possibly derived from platelets 
PTX3 binds selected conserved microbial molecules and has 
antibody-like functions: it has opsonic activity via Fc recep-
tors (Lu et al., 2008; Bottazzi et al., 2010), activates and regu-
lates the complement cascade (Bottazzi et al., 2010; Ricklin and 
Lambris, 2013), and regulates inflammation (Bottazzi et al., 2010; 
Deban et al., 2010). Genetic evidence in mouse and man indi-
cates that PTX3 is essential for resistance against selected 
pathogens, such as Aspergillus fumigatus, Pseudomonas aeruginosa, 
and Klebsiella pneumoniae (Garlanda et al., 2002; Bottazzi et al., 
2010; Cunha et al., 2014; Jaillon et al., 2014), and plays a pro-
tective role in different conditions associated with tissue in-
jury (Salio et al., 2008; Norata et al., 2009; Bottazzi et al., 2010; 
Deban et al., 2010).
Cellular sensors of tissue damage include TLRs and NOD-
like receptors, which sense endogenous products of damaged 
cells and tissues, including extracellular matrix components 
and nucleic acids, and activate the production of inflamma-
tory mediators and the recruitment of innate immune cells, 
such as macrophages and neutrophils, initiating tissue repair 
processes (Medzhitov, 2008). Components of the humoral arm 
of innate immunity involved in tissue damage, for instance in 
ischemia/reperfusion injury, include mannose-binding lectin 
and lectins, which upon binding altered host cells, promote acti-
vation of the lectin complement pathway contributing to tis-
sue damage (Genster et al., 2014).
In the context of an effort aimed at dissecting the effector 
and regulatory function of PTX3 as a prototypic component 
of humoral innate immunity in tissue damage, we investigated 
its role in different tissue repair models. Here, we show that by 
interacting with the provisional matrix protein fibrin and with 
plasminogen, PTX3 plays a nonredundant protective role in 
the orchestration of tissue repair and remodeling.
RESULTS
Role of PTX3 in tissue repair
We investigated the role of PTX3 in models of tissue damage, 
including skin wounding, liver, and lung sterile tissue injury. 
A model of full-thickness excision dorsal skin wounding was 
first used. Wounding was associated with induction of in-
creased levels of PTX3 mRNA and protein in the skin and 
blood (Fig. 1, A and B). By confocal microscopy analysis, on 
day 2 PTX3 was found in the clot and mostly associated with 
aligned bundles of cells migrating toward the wound site, and 
epithelial outgrowth (Fig. 1, C and D). On day 7, PTX3 was 
scattered in the scab and damaged dermis (Fig. 1 C). At heal-
ing (day 14), PTX3 expression was confined to neo-formed 
tissue and residual scab (Fig. 1 C). In particular, on day 2 PTX3 
reported because of the low number of events acquired. Ptx3+/+ (n = 7 independent mice), Ptx3/ (n = 6 independent mice). (I) PTX3 mRNA expression 
was assessed in sorted macrophages (P2, CD45+ CD11b+ Ly6C+ F4/80) and mesenchymal cells (P4, CD45 PDGFR+) 2 d after wounding by quantitative  
RT-PCR. Results are presented as absolute values. Analysis of five Ptx3+/+ and four Ptx3/ independent mice was performed in triplicate. Peritoneal elic-
ited cells (PEC), untreated or treated with LPS (10 ng/ml; 4 h), were used as control. (J and K) PTX3 plasma levels (J) and wound content (K) were measured 
in WT (n = 11–14) and MyD88- (n = 6), IRF3- (n = 6), TLR3- (n = 8), IL-1R1- (n = 6) and TRIF-deficient (n = 6–7) independent mice. Graphs show the 
mean ± SD (A, H, and I) or box plots (B, J, and K). *, P < 0.05; **, P < 0.01; and ***, P < 0.005 versus day 0 (A and B), or WT at the same time point (J and K; 
Mann-Whitney test).
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Figure 2. Skin repair is altered in PTX3-deficient mice. The skin wound healing model was used. (A) Representative macroscopic images of WT and 
Ptx3/ skin wounds are shown at the indicated days after wounding. Bars, 5 mm. (B) Kinetic analysis of skin excisional wound areas was performed. 
Values represent mean ± SEM. *, P < 0.01 (Student’s t test). One representative experiment (n = 10 mice/group) out of 15 is shown. (C) Representative 
histological images (H&E) of wound healing are shown for Ptx3+/+ and Ptx3/ mice at the indicated days after wounding. C, clot; wb, wound bed; s, scab; 
e, epithelialization; n, neo-formed tissue; arrowheads, hair follicles. Bars, 200 µm (2d, 7d) and 50 µm (14d). n = 8 mice. (D) Fibrin deposition and CD68+ 
invading cells in WT and Ptx3/ wounds on day 2 were assessed by immunofluorescence confocal microscopy. Arrowheads: aligned CD68+ cells migrat-
ing toward the wound bed; right, dashed arrows: passages formed within the fibrin-rich wound site and directionality of invading CD68+ cells. C, clot; wb, 
wound bed. Representative images (n = 11 WT; n = 14 Ptx3/ mice) are shown. Bars, 100 µm (left) and 10 µm (right). (E, left) Single fluorescence confo-
cal microscopy images of fibrin (shown in D) are presented for Ptx3+/+ and Ptx3/ wounds on day 2. Bars, 100 µm. (right) fibrin staining quantification in 
the clot or in the wound bed is shown. Data are presented as mean ± SD; n = 2–3 10X images/mouse, 5 mice/group. ****, P < 0.0001, (Mann-Whitney test). (F) 
PDGF, TGF, CD62P, serotonin (5HT), CXCL1, and CXCL2 protein levels from WT and PTX3-deficient wound lysates after skin injury (day 1) were assessed by 
ELISA. Graphs show the mean ± SD. *, P < 0.05, **, P < 0.01 and ***, P < 0.005 versus WT (Mann-Whitney test); n = 8–10 independent mice/group. (G, top) 
Western blot analysis of thrombin in WT and PTX3-deficient wound lysates (day 1) was performed. Proteins, 20 µg/lane; mouse plasma-ACD, 1 µl/lane. 
Vinculin (middle) used as loading control and Ponceau red (bottom) staining are also shown. (bottom) Results are expressed as mean ± SD gray values of 
 o
n
 June 17, 2015
jem.rupress.org
D
ow
nloaded from
 
Published May 11, 2015
JEM Vol. 212, No. 6
Article
909
with increased clotting and excessive fibrin accumulation on 
day 2, followed by thicker scabs, augmented collagen deposi-
tion, and delayed reepithelialization on day 7, and epithelial 
hyperplasia and defective mature tissue formation on day 14, 
which are all signs of defective repair (Romer et al., 1996).
In an effort to extend these observations to models of sterile 
injury, we studied CCl4-induced liver injury and acid-induced 
lung damage, in which genetic deficiencies causing prothrom-
botic responses are associated with impaired tissue remodel-
ing and fibrosis (Pohl et al., 2001; Idell, 2003; Calvaruso et al., 
2008). PTX3 plasma levels increased in the blood after acute 
liver injury (8–48 h), as well as chronic injury (6 wk), and re-
turned toward basal levels at resolution of fibrosis (Fig. 4 A). 
PTX3 localized in necroinflammatory areas associated with 
GR1+ cells (8–48 h), and in the portal tracts associated with 
uPA+, PDGFR+, and CD68+ cells (6 wk; unpublished data). 
PTX3 deficiency did not affect necrosis (8–48 h; unpublished 
data); however, it was associated with an increased number 
of thrombosed centrolobular veins 8 h after CCl4 injection 
(69.61 ± 17.16% in Ptx3/ mice compared with 20.80 ± 
8.46% in WT mice; n = 4; P = 0.011; Fig. 4 B); augmented 
deposits of eosinophilic material rich in fibrin in necroinflam-
matory areas of lobular spaces close to the centrolobular vein 
at 24 and 48 h, and in the portal tracts after chronic injury 
(6 wk; Fig. 4, B and C); augmented fibrosis assessed by mea-
surement of liver -SMA+ immunoreactive area (Fig. 4 D); 
and OH-proline content (Fig. 4 E), Sirius red, and collagen I 
staining at portal septa (Fig. 4, F and G; 6 wk). Similarly, in the 
acid-induced lung injury model, we observed increased fibrin 
deposition at day 7 (Fig. 4 H) and increased collagen content 
at day 30 in Ptx3/ mice (Fig. 4 I). Finally, PTX3-deficient mice 
were more susceptible to arterial thrombosis in a model of 
FeCl3-induced vascular injury (Koschnick et al., 2005; Fig. 5 A), 
and exogenous PTX3 reversed the phenotype in Ptx3/ mice 
and reduced the severity in Ptx3+/+ mice (Fig. 5, B and C). 
These results suggest that in different models of tissue injury, 
PTX3 deficiency is associated with increased clotting and 
fibrin deposition and alteration of tissue repair, thus indicating 
that PTX3 has a protective role in tissue damage.
PTX3 binds P-selectin and has a negative regulatory func-
tion in selected models of inflammation (Bottazzi et al., 2010; 
Deban et al., 2010). Given the role of leukocytes in the orchestra-
tion of tissue repair, it was important to ascertain whether the 
altered wound healing observed in Ptx3/ mice was in fact 
the expression of deregulated leukocyte recruitment. The analy-
sis of leukocyte recruitment by immunohistochemistry, flow 
cytometry and confocal microscopy in skin and liver, and my-
eloperoxidase (MPO) content in skin wound lysates showed 
no difference in the total number of recruited cell populations 
(polymorphonuclear cells and macrophages) in the two groups 
(Nurden, 2011; Semple et al., 2011; Fig. 2 F), and thrombin 
(Fig. 2 G) were measured in PTX3-deficient wounds on day 1. 
Higher expression of markers of differentiated and activated 
fibroblasts was observed at day 2 (Fig. 2, H and I). Some of 
these factors (e.g., PDGF, TGF, serotonin, and thrombin) 
acting on stromal cells may well be responsible for increased 
early wound contraction and reduction of wound area ob-
served in Ptx3/ mice (Singer and Clark, 1999; Schäfer and 
Werner, 2008). Despite the accelerated reduction of wound 
area, PTX3 deficiency was associated with a defective reepi-
thelialization at day 7 (the epithelial gap was 3,002 ± 432 µm 
and 1,306 ± 503 µm in Ptx3/ and WT mice, respectively; 
P = 0.026; n = 7) and epithelial hyperplasia (10.8 ± 0.8 epi-
thelial layers in Ptx3/ vs. 6.0 ± 1.4 in WT mice; P = 0.0001; 
n = 8) and defective development of skin appendages at day 14, 
suggesting a defective mature tissue formation (Fig. 2 C). At 
later time points (25 d after wounding), the epithelial layers 
did not differ in the two groups (3.2 ± 1.1 epithelial layers in 
Ptx3/ skins compared with 3.4 ± 1.3 in Ptx3+/+ skins; 
n = 5), or in unwounded skins (unpublished data), indicating 
that epithelial hyperplasia associated with altered skin wound 
healing in PTX3-deficient mice was a transient event. Vascu-
lar density was not affected by PTX3 deficiency (day 2, 11 ± 7 
vs. 17 ± 11; day 7, 42 ± 16 vs. 47 ± 16; day 14, 49 ± 17 vs. 
43 ± 16 CD31+ vessels/mm2 in Ptx3+/+ vs. Ptx3/; n = 4–6; 
P = ns).
At the beginning of new tissue formation, remodeling cells 
enter the wound, allowing the replacement of the fibrin matrix 
by mature granulation tissue rich in type I collagen, as well as 
other extracellular matrix (ECM) proteins (Romer et al., 1996; 
de Giorgio-Miller et al., 2005). PTX3 deficiency was associ-
ated with alterations in the organization of remodeling cells 
invading the injured area. As previously shown (Singer and 
Clark, 1999), in WT mice, CD68+ macrophages (Fig. 2 D) and 
PDGFR+ mesenchymal cells (not depicted) collectively mi-
grated toward the wound bed and the clot, creating patent pas-
sages within fibrin matrix (Fig. 2 D). In Ptx3/ mice, CD68+ 
macrophages and PDGFR+ cells were scattered in the abun-
dant fibrin-rich matrix and failed to create patent passages, sug-
gesting defective directional migration and invasive phenotype 
(Fig. 2 D). Wound collagen was evaluated by collagen I and 
Sirius red staining. On day 7, collagen content was higher in 
Ptx3/ tissues after wounding compared with WT (Fig. 2 J). 
Treatment with recombinant PTX3 reversed the phenotype 
of Ptx3/ mice (Fig. 3, A–G) and had a significant effect on 
collagen deposition at one time point (day 7) in WT mice, sug-
gesting that endogenous PTX3 is sufficient for gross biologi-
cal function. The N-terminal domain, but not the C-terminal 
one, was necessary and sufficient to revert the phenotype (Fig. 3, 
A–G). Thus, after skin wounding, PTX3 deficiency was associated 
thrombin/vinculin. (n = 6 mice/group). ***, P < 0.005 (Mann-Whitney test). (H and I) Representative confocal microscopy immunofluorescence staining 
images (left) and quantification (right) of -SMA (green), FAP (red) and PAR1 (white) in WT and PTX3-deficient wounds are shown. *, P < 0.05, **, P < 0.01 
and ***, P < 0.005 versus WT (Student’s t test); n = 3–4 20X images/mouse, (n = 4–7 mice/group). (J) Collagen I (COL1A1) and Sirius red staining in the 
wounds at day 7. Representative images are shown (n = 5 mice). Bars, 100 µm.
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Figure 3. Alterations in skin wounding are rescued by exogenous PTX3. (A–C) After skin wounding in Ptx3+/+ and Ptx3/ mice, the effect of recombi-
nant PTX3 (A and B) and its N- or C-terminal domains (N or C domain; A and C) on wounded skin area was assessed. (A) Representative macroscopic im-
ages of skin wounds were obtained at day 2. Bars, 5 mm. (B and C) Kinetic analysis of skin excisional wound areas was performed. (B) *, P < 0.01, Ptx3/ 
treated with PTX3 versus Ptx3/ (Student’s t test). One representative experiment (n = 10–12 mice/group) out of 2 is shown. (C) #, P < 0.005, Ptx3/ 
treated with the N-domain versus Ptx3/ (Student’s t test). One representative experiment (n = 8–10 mice/group) out of 3 is shown. (D)The effect  
of treatment with PTX3 and its N- and C-terminal domains on wound healing was evaluated by histological (H&E) staining at the indicated days in  
WT versus Ptx3/ mice. C, clot; wb, wound bed; s, scab; e, epithelialization; n, neo-formed tissue; arrowheads, hair follicles. Bars: (2 d and 7 d) 100 µm; 
(14 d) 20 µm. Representative images are shown (n = 4 mice). (E) Fibrin deposition and CD68+ invading cells in WT and Ptx3/ wounds after treatment 
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blocked PTX3 binding to fibrin but not to Plg. mAb MNB5, 
which recognizes the C-terminal domain, had no effect 
(Fig. 7 H). Moreover, no competition for binding to PTX3 
was observed between fibrin and Plg. Actually, in the pres-
ence of PTX3, Plg bound to fibrin more efficiently; similarly, 
in the presence of Plg, PTX3 bound to fibrin more efficiently 
(Fig. 7 I). In competition experiments PTX3 binding to Plg 
was inhibited by l-lysine (Lys; ligand of Lys-binding sites in 
Plg Kringles [KRs] 1, 2, 3, and 5) and l-arginine (specific li-
gand of KR5; Law et al., 2012; not depicted). Moreover, PTX3 
bound Plg KR3-KR5 fragment, but not KR1-KR3 fragment 
(Fig. 7 J). These data suggest that PTX3 interacts with Plg KR5, 
which triggers the Plg conformational change leading to the 
open form, and does not interact with Plg KR1 domain, which 
mediates the initial recruitment of closed Plg to the C-terminal 
Lys moieties of fibrin or cell surface (Law et al., 2012). All to-
gether, these data suggest that PTX3 interaction with fibrin 
and Plg occurred via different sites in the PTX3 N-terminal do-
main and that interaction of PTX3 with Plg did not interfere 
with fibrin binding to Plg, and occurred via a different site.
No pH-dependence was observed in the PTX3 interaction 
with microbes such as A. fumigatus conidia, P. aeruginosa and 
Escherichia coli, or OmpA from K. pneumonia (not depicted).
Functional relevance of PTX3 interaction  
with fibrin and plasminogen
In an effort to investigate the actual functional relevance of 
the interaction of PTX3 with FG/fibrin and Plg, an in vitro 
fibrinolysis assay was used. At pH 6.0 fibrin gel degradation 
mediated by plasmin and triggered by uPA and tissue plasmin-
ogen activator (tPA) was potentiated in the presence of PTX3, 
which had no activity on its own (Fig. 7 K). No potentiation 
was instead observed at neutral pH (pH 7.4, not depicted, and 
7.6; Fig. 8).
The finding that PTX3 interacted with FG/fibrin and Plg, 
and facilitated fibrin dissolution at low pH raised the issue of 
the actual in vivo occurrence and functional relevance of this 
interaction during wound healing. After skin wounding, colo-
calization of PTX3 and fibrin and Plg was observed by con-
focal microscopy in the clot (Fig. 8 A) and in the pericellular 
matrix of invading cells or associated with Plg+ cells at day 2 
(Fig. 8 B). Similarly, PTX3 colocalized with fibrin upon liver 
and lung injury (unpublished data). Treatment with dichloro-
acetate (DCA) to revert local acidosis inhibited the colocaliza-
tion between PTX3 and fibrin or Plg, but not between fibrin 
and Plg (Fig. 8, C and D). Two-photon microscopy was then 
used to simultaneously measure the pH using a pH-sensitive 
fluorescent probe (BCECF) and to visualize PTX3 and 
fibrin and Plg colocalization in the wounded skin area in vivo 
(Fig. 6, A–C and not depicted). Moreover, skin wound heal-
ing was performed in double-deficient Ptx3/ P-selectin/ 
mice. First P-selectin deficiency had no notable effect on skin 
healing (Fig. 6 D). Moreover, PTX3/P-selectin double-deficient 
mice showed a wound healing phenotype identical to that of 
Ptx3/ mice (Fig. 6 D), suggesting that interaction between 
PTX3 and P-selectin does not play a major role in the alterations 
of wound healing observed in PTX3 deficient hosts. Thus, al-
tered P-selectin-dependent leukocyte recruitment is not respon-
sible for the alterations in tissue repair observed in Ptx3/ mice. 
However, as stated above, in Ptx3/ mice CD68+ macro-
phages and PDGFR+ cells failed to collectively migrate into 
the fibrin-rich skin wound site.
Interaction of PTX3 with fibrin  
and plasminogen at acidic pH
The finding that excessive clot and thrombi formation and fibrin 
deposition and persistence were consistent phenotypes in tissue 
damage models in Ptx3/ mice and the role of fibrin as a pro-
visional matrix protein guiding subsequent repair (Carmeliet 
et al., 1994; Bugge et al., 1996; Romer et al., 1996; Singer and 
Clark, 1999; Schäfer and Werner, 2008) prompted us to inves-
tigate the interaction of PTX3 with components of the coag-
ulation and fibrinolytic cascade. We were also prompted in this 
direction by the finding that PTX3 interacts with ficolins via 
their fibrinogen domain (Ma et al., 2013). Previous studies 
indicating that PTX3 induced procoagulant activity in endo-
thelial cells and monocytes (Napoleone et al., 2002) could not 
be reproduced on repeated attempts (unpublished data). PTX3 
bound fibrinogen (FG) and plasminogen (Plg), but it did not 
bind other components of the coagulation cascade (listed in 
Materials and methods; unpublished data). When FG, fibrin, 
and Plg were immobilized on plastic wells, pH-dependent 
binding was observed, with optimal interaction at pH 5.5–6.5 
(Fig. 7 A). In the same setting, C-reactive protein (CRP) did 
not bind FG, fibrin, or Plg (Fig. 7 B). Binding of PTX3 to 
fibrin and Plg was Ca2+ independent and unaffected by treat-
ment with endoglycosidase F3 or/and neuraminidase (unpub-
lished data). The apparent dissociation constants (Kd) evaluated 
by nonlinear fitting analysis at pH 6.0 were 31.2 ± 10.5 nM, 
7.5 ± 0.9 nM and 66.7 ± 25.1 nM for interaction with FG, 
fibrin, and Plg, respectively (Fig. 7 C). The N-terminal domain 
bound FG, fibrin, and Plg, whereas the C-terminal pentraxin 
domain bound with low-affinity only Plg (Fig. 7 D). The analy-
sis of binding was extended by surface plasmon resonance 
(Fig. 7, E–G), which showed higher affinity (Kd) of PTX3 or the 
N-terminal domain for Plg at pH 6.0 than at pH 7.4, due to a 
faster association rate (Kon) at acidic pH. Addition of mAb MNB4, 
directed against the PTX3 N-terminal domain, completely 
with PTX3 and N-terminal and C-terminal domains (day 2) was assessed by immunofluorescence staining. Representative confocal microscopy images are 
shown (n = 5–7 mice). Dashed arrows shows passages within the fibrin matrix in wound site created by CD68+ cells and direction of invasion toward the 
wound bed. Bars, 10 µm. (F and G) The effect of PTX3 or domain administration on Collagen I (COL1A1) deposition was assessed in the wounds at day 7 
by immunofluorescence staining. (F) Bars, 100 µm. Representative confocal microscopy images are shown. G, quantification of COL1A1 deposition is 
shown from F. Results are mean percentage and SD (n = 2–3 10× images/mouse, 4–9 mice/group). *, P < 0.05; ***, P < 0.005 (Mann-Whitney test).
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Figure 4. Liver and lung repair is altered in PTX3-deficient mice. Liver and lung injury were induced as described in Materials and methods.  
(A) PTX3 plasma levels after acute (8-48 h) and chronic (6 wk) CCl4 treatment, or at resolution of fibrosis were measured. -, treatment with mineral oil as 
vehicle. Graphs are presented as box plots. *, P < 0.05; ***, P < 0.005 (Mann-Whitney test); (n = 5–9 independent mice). (B) Representative hematoxylin-
eosin and immunofluorescence confocal microscopy images of fibrin in liver sections of WT and Ptx3/ mice are shown. Black arrowheads, centrolobular 
vein thrombi; blue and white arrowheads, deposits of eosinophilic material-fibrin in necroinflammatory areas (blue) at lobular spaces (24 and 48 h) and in 
the portal tracts (white) after chronic injury. Bars, 100 µm. (C) Quantification of fibrin staining in the liver was performed on samples from B. Mean ± SD; 
(B and C) n = 3–8 20× images/mouse, 4–6 mice/group. *, P < 0.05; **, P < 0.005; ***, P < 0.001; ****, P < 0.0001 (Mann-Whitney test). (D) Representative 
immunohistochemistry images for -SMA (left) and quantification of the immunoreactive areas (right) are shown for WT and Ptx3/ mice. Results are 
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of the damaged dermis (the analysis of the pH in the wound it-
self was technically impossible because of the endogenous auto-
fluorescence of the clot) the pH was acidic (6.77 ± 0.5; P = 
0.011; range, 5.67–7.87; Fig. 8 E and Fig. S2), which suggests 
cellular metabolic adaptation to trauma-induced tissue hypoper-
fusion and hypoxia (Schneider et al., 2007). In the z-projection 
(14 optical sections of 10 µm) of the dermis between the perile-
sion area and the wound, a significantly higher colocalization 
(Supplemental material). The surface of the skin normally has 
an acidic extracellular pH with values ranging from 4.5 to 6, 
due to the hydrolysis of skin lipids to free fatty acids, whereas 
lower epidermis and dermis have a neutral-alkaline extracellu-
lar pH in the range of 7–9 (Hanson et al., 2002). Accordingly, 
in the dermis (depth 10–20 µm) of unwounded skin, the pH 
measured by two-photon microscopy was 7.63 ± 0.5 (mean ± 
SEM; range 6.53–8.73; mean ± ). In contrast, in the proximity 
mean ± SD. ***, P < 0.005 (Student’s t test); n = 7–10). 20× images from 4 mice. (E) Collagen deposition in WT and Ptx3/ mice was assessed after 
chronic injury and measured as liver OH-proline (OHpro) content. (n = 9 WT and n = 10 Ptx3/ independent mice). Results are mean ± SD. *, P < 0.05 
(Student’s t test). (F) Representative microscopy images for Sirius red and COL1A1 staining in portal septa are shown. Bars, 100 µm. (G) Quantification of 
liver Sirius red staining at 6 wk and in the resolution phase (res) in WT and Ptx3/ mice after CCl4 injection from F. Results are presented as the mean 
percentage fibrotic area ± SD (n = 5–7 mice). *, P < 0.05; ***, P < 0.005 (Student’s t test). (H) Fibrin deposition in Ptx3/ and WT lungs was assessed using 
immunofluorescence staining 7 d after injury. Representative confocal microscopy images are shown (left) and fibrin staining quantification is presented 
(right). Bars, 100 µm. Mean ± SD; n = 3–5 10× images/mouse, 3 mice/group. ***, P < 0.0001 (Mann-Whitney test). (I) OH-proline (OHpro) content was 
measured in Ptx3/ and WT lungs, 30 d after injury. ***, P < 0.005 (Student’s t test). n = 17 WT and 29 Ptx3/ independent mice.
 
Figure 5. The thrombotic response is increased in PTX3-deficient mice. A model of FeCl3-induced arterial injury was used. (A) Induction of 
arterial thrombosis in WT and Ptx3/ mice was assessed after topical application of FeCl3 (10%). (B and C) The effects of PTX3 on thrombus forma-
tion in Ptx3/ (FeCl3 10% [B]) and WT (FeCl3 20% [C]) mice were also assessed. (A–C) Left panel shows carotid artery blood flow expressed as relative 
percentage compared with the value before injury. Middle panels show the average of carotid artery blood flow measured in the observation period 
(3–30 min). Results are presented as mean percentage ± SEM. A, (n = 11 WT and 17 Ptx3/ mice); B, (n = 4 WT and 4 Ptx3/ mice); C, (n = 8 WT and 
9 Ptx3/ mice). (A–C) *, P < 0.05; **, P < 0.01; ***, P < 0.005 (Student’s t test). (A–C, right) Representative histological H&E microscopy images of 
carotid arterial thrombi. Bars, 100 µm.
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Moreover, PTX3-deficient wounds showed decreased Plg 
deposition and plasmin formation (Fig. 9, A and B), and lower 
levels of D-dimer compared with WT lesions at day 2 after 
wounding (Fig. 9 C).
Macrophages are key players in tissue repair, orchestrate peri-
cellular fibrinolysis in vitro and in vivo (Carmeliet et al., 1994; 
Cook et al., 2006), and are major sources of PTX3 (Martinez 
et al., 2009). Because of these factors, and in light of the de-
fective invasive phenotype of macrophages observed in Ptx3/ 
mice (Fig. 2 D), we assessed pericellular fibrinolysis mediated 
by Ptx3/ macrophages. As shown in Fig. 9 D, Ptx3/  
of PTX3 and plasminogen was measured in a representative 
lower pH region than in a representative higher pH region 
(Fig. 8, F and G) of the wound site, with Pearson’s coefficients 
of 0.28 ± 0.03 and 0.15 ± 0.03, respectively (P = 0.007). Simi-
larly, a significantly higher colocalization of PTX3 and fibrin was 
observed in the lower pH area (Pearson’s coefficients: 0.83 ± 
0.05 and 0.63 ± 0.07 in lower pH and higher pH regions, 
respectively, P = 0.005). Binding of PTX3 to fibrin and Plg 
(Fig. 8 H), and amplification of cell free fibrinolytic activity by 
PTX3 (Fig. 8, I and J) were confirmed at the mean pH mea-
sured by two-photon microscopy in wounded skin (pH 6.77). 
Figure 6. Total leukocyte infiltration was not impaired in Ptx3/ skin wound. Skin wounding was performed. (A) An analysis of leukocytes infil-
trating the wound site (day 1) by cell flow cytometry was performed for Ptx3+/+ and Ptx3/ mice. Quantification histograms are shown for the indicated 
cell populations. Results are presented as mean percentage ± SD; n = 4 independent mice each. (B) MPO content was measured in the course of wound 
healing at days 1, 2, 7. n = 8–10, day 1; n = 10 and 11, day 2; n = 6 and 8, day 7, WT and Ptx3/ independent mice, respectively. (C) Representative  
immunofluorescence confocal microscopy images of CD45+ and Ly6G+ staining in the clot and damaged dermis 2 d after injury are shown. (left) Merged or 
single confocal images are shown (CD45, red; Ly6G, green; nucleus, blue). Bars, 50 µm. (right) MFI quantification in the entire field of view is shown. Data 
are presented as mean ± SD; (n = 5–7 mice; 4–12 images per mouse were analyzed). (D) A kinetic analysis of skin excisional wound areas in WT, Ptx3-, 
P-selectin-, and P-selectin–Ptx3–deficient mice was performed. Values represent mean ± SEM of one representative experiment out of two (n = 7–9 mice/
group). #, P < 0.05, P-selectin//Ptx3/ compared with P-selectin / mice and *, P < 0.05, P-selectin / compared with WT (Student’s t test).
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Figure 7. PTX3 interacts with fibrinogen, fibrin, and plasminogen. (A–D) A microtiter binding assay was performed to assess the interaction be-
tween PTX3 or CRP to fibrinogen (FG), fibrin, and plasminogen (Plg) in vitro. (A) The binding of PTX3 (22 nM) to FG, fibrin, and Plg at different pHs was 
assessed. Results are expressed as mean ± SD. One representative experiment in triplicate out of 5 is shown. (B) The binding of PTX3 and CRP to FG, fibrin, 
and Plg at pH 7.4 or 6.0 was also assessed. One representative experiment in triplicate out of three is shown. (C) Fitting analysis of biotinylated (b-) PTX3-
FG–fibrin–Plg interactions. Mean values of 6 (FG and Fibrin) or 3 (Plg) experiments are shown. (D) Binding of b-PTX3 and b-C-terminal or b-N-terminal 
domains (4.4 nM) to FG, fibrin, Plg at pH 6.0 was assessed. One representative experiment in triplicate out of seven is shown. (E–G) Surface plasmon 
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formation and reduced blood flow. Collectively, these data in-
dicate that PTX3 plays an essential role in the orchestration 
of a tissue injury response, in agreement with previous stud-
ies (Salio et al., 2008; Norata et al., 2009; Deban et al., 2010; 
Rodriguez-Grande et al., 2014).
In the skin wound model, which was more deeply inves-
tigated, the major sources of PTX3 throughout the course 
of healing were stromal cells of mesenchymal origin, whereas 
neutrophils and macrophages contributed in the early phase. 
TLR and IL-1 are key activators of the inflammatory and re-
parative responses in tissue injury and potent inducers of PTX3 
(Medzhitov, 2008; Dinarello, 2009; Bottazzi et al., 2010). Re-
sults obtained with mice deficient of components of the TLR 
or IL-1 signaling pathway (IL-1R, MyD88, and TRIF) indi-
cate that after tissue damage, the induction of PTX3 was down-
stream of TLR sensing and IL-1 amplification and required 
both MyD88- and TRIF-dependent signaling pathways. How-
ever, we cannot exclude that the low content of PTX3 in 
wounded skin of mice deficient of TLR or IL-1 signaling com-
ponents was also caused by defective recruitment of inflam-
matory cells at the wound site, as reported for TLR3-deficient 
mice (Lin et al., 2011).
PTX3 binds P-selectin via its glycosidic moiety and nega-
tively regulates leukocyte recruitment in P-selectin–dependent 
models of inflammation (Deban et al., 2010; Lech et al., 2013). 
The role of individual selectins in leukocyte recruitment and 
tissue repair in models of wound healing has been the object 
of conflicting reports (Subramaniam et al., 1997; Yukami et al., 
2007; Tomita et al., 2009). In an effort to assess whether the 
role of PTX3 in the orchestration of wound healing was 
dependent on its interaction with P-selectin, double deficient 
mice were used. We found that the alterations in wound heal-
ing were identical in Ptx3/ and Ptx3/ /P-selectin/ mice. 
Thus, the role of PTX3 in the orchestration of tissue repair in 
skin wound healing is P-selectin independent.
It has been previously demonstrated that recombinant PTX3 
at supraphysiological concentrations (10–40 µg/ml) interferes 
with platelet aggregation induced by thrombin receptor agonist 
peptide-6 (TRAP) and collagen (Maugeri et al., 2011). How-
ever, results obtained with gene-targeted mice indicated that 
PTX3 deficiency does not impact on platelet aggregation (un-
published data). This suggests that at physiological concentration 
PTX3 is not involved in this process and that the phenotypes de-
scribed here do not depend on increased platelet aggregation.
peritoneal macrophages showed defective fibrinolytic activity 
compared with WT cells. Similar results were obtained with 
PTX3-deficient and -sufficient embryonic fibroblasts (Fig. 9, 
E and F).
In an effort to assess whether an interaction with key com-
ponents of the coagulation/fibrinolysis system actually un-
derlies the role of PTX3 in wound healing, pharmacologic 
inhibitors of fibrin deposition with different molecular tar-
gets were used. These included antithrombin III (ATIII; an 
inhibitor of thrombin and Factor Xa), Argatroban (thrombin 
inhibitor), and Batroxobin (which depletes fibrinogen). In the 
presence of these inhibitors of the coagulation cascade, the 
differences in skin wound healing (accelerated reduction of 
wound area and collagen accumulation) between PTX3- 
competent and -incompetent mice were abolished (Fig. 10, A–F).
DISCUSSION
The results reported here show that a prototypic component 
of humoral innate immunity, the long pentraxin PTX3, plays 
a nonredundant role in the orchestration of tissue repair and 
remodeling. In different models of tissue damage, PTX3 de-
ficiency was associated with increased fibrin deposition and 
persistence, followed by increased collagen deposition. In ad-
dition, after injury, PTX3 interacted with FG/fibrin and Plg 
at acidic pH and, based on in vitro findings, this tripartite in-
teraction promoted fibrin degradation, which is a premise for 
appropriate repair.
Major defects in skin wound healing in PTX3-deficient 
mice included increased clotting, excessive fibrin accumulation, 
and delayed reepithelialization at early time points, followed 
by augmented collagen deposition, epithelial hyperplasia, and 
defective mature tissue formation at healing. Delayed reepi-
thelialization followed by epithelial hyperplasia are signs of 
defective repair, which have been associated to impaired deg-
radation of the extracellular matrix by leading edge kera-
tinocytes and excessive keratinocyte proliferation, respectively 
(Lund et al., 2006). In two other models studied (liver and 
lung injury), we observed that tissue damage was associated with 
increased fibrin deposition and collagen content. Results pre-
sented here on the interaction of PTX3 with fibrin and plas-
minogen suggest that defective pericellular fibrinolysis of 
remodeling cells associated to PTX3 deficiency is responsi-
ble for these defects. Along the same line, in arterial thrombo-
sis, PTX3 deficiency was associated to increased thrombus 
resonance (SPR) sensorgrams were obtained by injecting different concentrations of PTX3 (E) or PTX3 N-terminal domain (F) over immobilized Plg. (G) SPR 
analysis was performed at pH 6.0 flowing monomeric Plg onto immobilized PTX3 or N-terminal domain. (E–G) One representative experiment out of two 
is shown. (H–J) Microtiter binding assays were performed to define which PTX3 domain and plasminogen fragment are involved in the interaction.  
(H) PTX3 binding to fibrin and Plg in the presence of antibodies anti–N-terminal (MNB4) or anti–C-terminal (MNB5) domains or irrelevant IgG was as-
sessed as shown. One representative experiment in triplicate out of three is shown. (I) The binding of PTX3 (top) or Plg (bottom) to fibrin in the presence 
of Plg or PTX3, respectively, and of CRP and BSA used as controls, at pH 6.0 was assessed as shown. One representative experiment in triplicate out of two 
is shown. *, P < 0.05; #, P < 0.001. Values are mean ± SD. (J) The binding of PTX3 to Plg fragments, at pH 6.0 was assessed as shown. One representative 
experiment in triplicate out of 4 is shown. (K) Western blot analysis of fibrin clots prepared by mixing FG and thrombin, digested at pH 6.0 by recombinant 
purified proteins in cell-free conditions, was performed. Red arrows indicate the presence of main products of fibrinolysis. One representative experiment 
out of five is shown.
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Figure 8. The interaction of PTX3 with fibrin and plasminogen occurs in vivo. Skin wounding was performed in untreated WT mice (A and B) or 
upon treatment with DCA (C). (A–C) Colocalization of PTX3, fibrin, and Plg in clot (A) and damaged dermis (B and C) of wounded skin at day 2 were as-
sessed. (A–C, left) Representative immunofluorescence confocal microscopy merged images of PTX3 (green), fibrin (white), Plg (red), and nucleus 
(blue). (A, right; B and C, middle) Representative merged images of PTX3 (green) and fibrin (white), or of PTX3 (green) and Plg (red). (B and C, right) 
Images of colocalization signal (yellow) of PTX3 with fibrin (PTX3-Fibrin) or plasminogen (PTX3-Plg). (B, top) Passages created by invading cells within 
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repair in different models, including skin wound healing and 
liver and lung injury (Carmeliet et al., 1994; Romer et al., 1996; 
Pohl et al., 2001; Idell, 2003; de Giorgio-Miller et al., 2005; 
Calvaruso et al., 2008). Thus, PTX3 acts as a molecular scaffold 
Fibrin and other provisional ECM proteins are transiently 
deposited after tissue injury and their subsequent degradation 
heralds tissue remodeling and scar formation. Genetic evidence 
points to an essential role of timely fibrin deposition in tissue 
fibrin rich-wound sites (dashed black arrows); (bottom) magnification image of PTX3 colocalization with fibrin and Plg at the pericellular matrix of cells 
invading the wound bed (white arrowheads) and with Plg+ invading cells (red arrowheads). Bars: (A, B [top], and C) 50 µm and (B, bottom) 5 µm. (C) The 
inhibition of colocalization after treatment with DCA was assessed 2 d after wounding. Representative confocal microscopy images are shown. White 
arrowheads denote colocalization between Plg and fibrin matrix. (A–C) n = 4–9 images/mouse, 4 mice/group. (D) Colocalization in the clot (left) and in the 
damaged dermis (right) of wounded skins (day 2) was quantified upon treatment with DCA (from samples in A–C and not depicted). The percentage of 
colocalized PTX3 with fibrin or plasminogen, and fibrin with plasminogen (top), and the relative Pearson’s coefficient (bottom) are shown. Each circle rep-
resents analysis from a single confocal image (2–3 fields of vision/mouse, n = 3–4 mice). *, P < 0.05; **, P < 0.01; ***, P < 0.005; ****, P < 0.0005; (Mann-
Whitney test). (E) Measurement of pH in the skin was assessed by two-photon microscopy in unwounded skin and at the periphery of the wound. The 
data represent mean ± SEM. BCECF lifetime and pH as a function of depth. (n = 5 mice/group). *, P < 0.05 (Student’s t test). (F) Representative two-photon 
microscopy images from D are shown. A tiling presentation of images showing the colocalization of PTX3, fibrin and Plg in areas of acidic pH (blue, lower 
intensity) at the wound site is presented (left). Inset, unwounded skin, control. Single fluorescence images are presented (right). Images are composite 
maximum intensity projections in the proximity of damaged dermis. Bars, 200 µm. Representative images from one mouse out of 10 WT mice analyzed 
are shown. (G) Colocalization analysis (Pearson’s coefficient) was measured for PTX3-Plg and PTX3-fibrin in insets a (blue higher intensity, higher pH)  
and b (blue lower intensity, lower pH) of panel F of PTX3 with fibrin or plasminogen. Data are presented as mean ± SD of 14 slices (10 µm) in the z axis. 
(H) The binding of PTX3 (22 nM) and CRP (22 nM) to FG, fibrin, and Plg was assessed at pH 7.73, 6.7,7 and 6.0 by microtiter binding assay. Data are  
presented as mean ± SD of one representative experiment in triplicate out of 2. (I and J) Western blot analysis (I) and quantification (J) of fibrin clots  
digested at pH 7.73, 6.77, and 6.0 by recombinant purified proteins in cell-free conditions was performed. I, On the right,  polymers,  dimers and , , 
and  subunits are shown. One representative experiment out of four is shown. (J) Results are expressed as mean ± SD. Gray intensity values in bands of 
 polymers,  dimers and , , and  subunits from four Western blots performed are shown.
 
Figure 9. The interaction of PTX3 with fibrin and plasminogen is functionally relevant. Skin wounding was performed in Ptx3+/+ and Ptx3/ 
mice. Representative confocal microscopy images (A) and Western blot analysis (B) of Plg/plasmin (white) at day 2 after skin wounding are shown. (A) Plg/
plasmin (white) and cells invading the wound bed (yellow arrowheads) are shown. Bars, 20 µm. (n = 2–5 40X images/mouse, 4 mice/group). (B) one repre-
sentative experiment out of 3 with 50 µg/lane of wound protein extract from 3 mice per genotype and 1 µl/lane of mouse serum is shown. Vinculin  
immunoblotting (loading control) is also shown. Results are expressed as mean ± SD gray intensity values of Plg or plasmin/vinculin. (n = 6 mice/group). 
(C) An ELISA of D-dimer in skin wound extracts on day 2 was performed. (n = 16 WT and 17 Ptx3/ independent mice). (D and E) An ELISA (left) and a 
Western blot analysis (right) of soluble fibrinolysis products generated by WT or Ptx3/ peritoneal macrophages in (D) or embryonic fibroblasts (MEFs) in 
(E) grown in fibrin clots as described in Materials and methods in 3 and 2 d of culture, respectively, are shown. (D) (left) Data are presented as mean ± SD 
of one representative experiment in triplicate with 2–3 independent mice out of 4; (right) one experiment of 2 performed is shown. (F) Representative 
confocal microscopy images of WT or Ptx3/ MEF after 2 d of culture in a fibrin matrix, to assess remodeling of the matrix, as well as apparent colocal-
ization of PTX3 and fibrin fibers in WT versus Ptx3/ cultures. (inset) PTX3 staining (red) and nucleus (blue) are shown. Bars, 50 µm. (E and F) One repre-
sentative experiment with three independent mice out of two is shown. (C–E) ***, P < 0.005 (Student’s t test).
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exon-encoded N-terminal domain of PTX3 recapitulated the 
activity of the whole molecule both in vitro and in vivo.
The interaction of PTX3 with FG/fibrin and Plg was much 
more efficient (from three- to fourfold) at acidic pH. An acidic 
favoring the interaction of Plg with fibrin and its timely deg-
radation as a premise for appropriate repair. This activity is pe-
culiar for PTX3 because short pentraxins did not show binding 
to fibrin, fibrinogen, or plasminogen. Accordingly, the second 
Figure 10. Inhibitors of coagulation and fibrin deposition rescue the phenotype of Ptx3/ mice in skin wound healing. (A–C) A kinetic analy-
sis of skin excisional wound areas after treatment with ATIII (A), Argatroban (B), and Batroxobin (C) was performed in WT and Ptx3/ mice; *, P < 0.005, 
Ptx3/ treated versus Ptx3/ (Student’s t test). One representative experiment with 8–10 mice/group out of 2 is shown. (D) Representative macroscopic 
images of WT and Ptx3/ skin wounds after treatment with ATIII, Argatroban, and Batroxobin at the indicated days after wounding are shown. (E and F) Repre-
sentative confocal microscopy images (E) and quantification (F) of COL1A1 deposition in wounded skin (on day 7) after treatment with the indicated 
pharmacological agents in WT and Ptx3/ mice from A–C are shown. (E) Bars, 100 µm. (E and F) Results are presented as mean percentage of area ± SD 
(n = 5–8 images from 4 mice/experimental group). **, P < 0.01; ***, P < 0.005 (Mann-Whitney test).
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described (Bottazzi et al., 1997; Deban et al., 2010). Purified OmpA from 
Klebsiella pneumonia was prepared as previously described (Jeannin et al., 2005). 
Rabbit polyclonal antibody to PTX3 and rat monoclonal antibodies anti-
PTX3 MNB4 (IgG2a) and MNB5 (IgG1) were obtained as previously de-
scribed (Camozzi et al., 2006). The rat isotype control was from AbCam 
(IgG1; #RTK2071). All proteins were at least 95% pure as assessed by SDS-
PAGE followed by silver staining.
Animals
PTX3-deficient mice were generated as previously described (Garlanda et al., 
2002) and were used on a 129/SvPas or C57BL/6J inbred (backcrossed for 
11 generations) genetic background. Wild-type mice were obtained from 
Charles River or were cohoused littermates (e.g., 2 out of 15 experiments 
for skin wound healing). Il1r1/, P-selectin/, Tlr3/, and Ticam1/ (all on 
a C57BL/6J genetic background) mice were from The Jackson Laboratory. 
Irf3/ and Myd88/ mice were provided by K.A. Fitzgerald (University of 
Massachusetts Medical School, Worcester, MA) and S. Akira (Osaka University, 
Osaka, Japan), respectively. Ptx3/P-selectin-double-deficient mice were gener-
ated by crossing single-deficient mice. Mice were housed in the specific 
pathogen–free animal facility of the Humanitas Clinical and Research Center 
in individually ventilated cages and were used between 8 and 12 wk of age. 
Procedures involving animals handling and care were conformed to protocols 
approved by the Humanitas Clinical and Research Center (Rozzano, Milan, 
Italy) in compliance with national (4D.L. N.116, G.U., suppl. 40, 18–2-1992; 
D.L. N. 26, G.U. 4–3-2014) and international law and policies (EEC Council 
Directive 2010/63/EU, OJ L 276/33, 22–09-2010; National Institutes of 
Health Guide for the Care and Use of Laboratory Animals, US National Re-
search Council, 2011). The study was approved by the Italian Ministry of 
Health (approval n. 71/2012-B, issued on the 09/03/2012). All efforts were 
made to minimize the number of animals used and their suffering.
Animal models
Skin wound healing. A punch wound was generated on the back of each 
mouse as previously described (Nakayama et al., 2010). In brief, the hair on the 
backs of mice (129/Sv or C57BL/6J) was shaved and exposed skin was cleaned 
with 70% ethanol. A full-thickness wound was created with disposable 8-mm-
diam biopsy punch by excising the skin and the underlying panniculus carno-
sus. Gentamicin was immediately applied and upon histological analysis no 
gross infection was apparent through day 14. Wound sites of each mouse were 
digitally photographed and measured every day in the course of wound heal-
ing. The edges of the wounds were daily traced onto a transparency, and the 
areas of open wounds were calculated using ImageJ software (National Insti-
tutes of Health [NIH]; Nakayama et al., 2010). Changes of wound area over 
time were expressed as percentage of the initial wound areas. To study the effect 
of recombinant PTX3 and its domains on wound healing, 50 µl/20 g body 
weight of PTX3 (50 µg/ml) and C and N domain (100 µg/ml) or PBS2+ were 
administered i.p. 4 h before injury, and then daily s.c. in the perilesion area. 
Rescue experiments were performed by treating WT and PTX3-deficient 
mice with antithrombin III (thrombin and Factor Xa inhibitor; 100 U/kg), 
Argatroban (thrombin inhibitor; 30 mg/kg), Batroxobin (FG depleting agent; 
30 BU/kg), and sodium dichloroacetate (DCA, pH 7.4, inhibitor of lactic acidosis; 
300 mg/kg) or vehicle, i.p. 4 h before injury and daily. Each treatment with 
Batroxobin caused FG depletion for 16-24 h. At indicated time points, mice 
were anesthetized by i.p. injection of 2.5% Avertin (Tribromoethanol; Sigma-
Aldrich), and blood was collected from the inferior vena cava. Skin biopsy 
specimens were obtained 2 and 7 d after wounding, and at healing (day 14) 
after cutting of wounds and surrounding areas with 8-mm-diam biopsy punches, 
and then extensively washed in ice-cold PBS2+, fixed with 4% paraformalde-
hyde, and embedded in paraffin or dehydrated with a sucrose gradient and 
embedded in OCT compound (Diapath) and stored at 80°C, for histology 
studies or confocal microscopy analysis, respectively.
Liver injury. Mice (129/Sv) were injected s.c. with 50 µl/20 g of carbon tet-
rachloride (CCl4) dissolved in a 1:1 ratio with mineral oil (Sigma-Aldrich), as 
pH ranging from 5.5 to 6.9 occurs at sites of tissue injury 
(Schneider et al., 2007) and in growing tumors (Gatenby and 
Gillies, 2004). The Plg activators uPA and tPA are neutral pro-
teases (Hamilton, 1980) and accordingly, we observed that cell-
free fibrinolysis was less effective at acidic pH compared with 
neutral pH. The presence of PTX3 in the assay increased fibri-
nolysis efficiency at acidic pH. Thus, the pH dependence of the 
binding of PTX3 to FG/fibrin and Plg ensures that it does not 
occur in the circulation but rather at sites of tissue repair, where 
it sustains fibrin matrix resolution in an acidic environment.
PTX3 is an essential component of humoral innate immu-
nity that interacts with microbial moieties, activates and regu-
lates the complement cascade and has opsonic activity via Fc 
receptors (Garlanda et al., 2002; Lu et al., 2008; Bottazzi et al., 
2010; Cunha et al., 2014). The results reported here suggest 
that, by interacting with the provisional matrix protein fibrin, 
PTX3 contributes to the orchestration of tissue repair and re-
modeling. The acidic pH, which occurs during tissue injury 
and repair (Schneider et al., 2007), is likely to act as a switch 
on signal for this function of PTX3.
Thus, an essential component of humoral innate immu-
nity has dual functions related to microbial and matrix recog-
nition. Matrix components such as fibronectin (Proctor, 1987), 
mindin (He et al., 2004), vitronectin (Gerold et al., 2008), and 
osteopontin (Schack et al., 2009) have opsonic activity for cer-
tain microbial species. Molecular phylogenetic analysis suggests 
that the ancestral function of fibrinogen-domain containing 
proteins is defense (Hanington and Zhang, 2011). Recent data 
highlight the connection and interplay between hemostasis 
and immunity (Semple et al., 2011; Wong et al., 2013). Fluid-
phase PRM, such as complement defense collagens (C1q and 
collectins; Groeneveld et al., 2005), SAP (Dyck et al., 1980), 
and CRP (Suresh et al., 2004), interact with ECM compo-
nents. Thus, recognition of both matrix and microbial com-
ponents is a recurrent theme in the humoral arm of the innate 
immune system. We suggest that recognition of microbial 
moieties and ECM components are evolutionarily linked and 
represent complementary, ancestral properties of humoral in-
nate immunity.
MATERIALS AND METHODS
Reagents
The following reagents were used: pyrogen-free saline (S. A. L.; Bergamo); 
RPMI 1640 medium (Biochrom); 200 mM l-glutamine (Biochrom); aseptically 
collected FCS (Hyclone Laboratories); thrombin and recombinant urokinase-
type Plg activator (uPA; R&D Systems); human plasma Plg-depleted FG, Glu-
Plg, tissue Plg activator (tPA), and CRP (EMD Millipore); Cascade Blue 
trisodium salt and 2,7-Bis-(2-Carboxyethyl)-5-(and-6)-carboxyfluorescein 
(BCECF free acid; Invitrogen); Coumarin 314 (Sigma-Aldrich); plasma anti-
thrombin III and Argatroban monohydrate (Sigma-Aldrich); Batroxobin 
(Pentapharm); recombinant Plg fragments KR1-KR3 (#ab73645; AbCam) 
and KR3-KR5 (#P00747; Gln274~Cys560; USCN Life Science Inc.); Fac-
tor II/Thrombin, Factor III, Factor VII, Factor XIV, V3, and PAI-1 (R&D 
Systems); and recombinant human Annexin II (AbD Serotec). Recombi-
nant human and mouse PTX3, and the PTX3 C-terminal (C domain) and 
N-terminal (N domain) fragments were purified under endotoxin-free con-
ditions by immunoaffinity, ion-exchange chromatography, and gel filtration, 
respectively, from the supernatants of stably transfected CHO cells as previously 
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before incubation (1 h at 25°C) with 100 µl of PTX3, biotin-conjugated 
C and N domain or biotin-conjugated PTX3 (b-PTX3; 3.5–222 nM) in PBS2+ 
(at indicated pH) containing 0.05% (vol/vol) Tween 20. After washing, PTX3, 
C and N domain, or bPTX3 were detected by incubation with 100 µl of purified 
polyclonal rabbit antibody (500 ng/ml) followed by horseradish peroxidase-
linked secondary antibody (GE Healthcare) or with 100 µl of horseradish 
peroxidase-linked avidin (BioSpa). Absorbance values were measured at 450 nm 
after addition of tetramethylbenzidine substrate (TMB; Sigma-Aldrich). A sim-
ilar protocol was used for CRP (EMD Millipore) and Plg (EMD Millipore) 
binding to fibrin. A rabbit polyclonal antibody anti-CRP (EMD Millipore) 
and a mouse monoclonal anti-Plg (IgG1; AbCam) were used, respectively. In 
different series of binding experiments, Plg and/or PTX3, CRP, and BSA 
(Sigma-Aldrich) were, respectively co-incubated with PTX3 or Plg.
Before binding experiments, CRP and the PTX3 C-terminal domain 
were cross-linked with BS3 (Bis[sulfosuccinimidyl]suberate; Thermo Fisher 
Scientific) according to the manufacturer’s instructions (Bottazzi et al., 1997).
PTX3 binding to conidia of Aspergillus fumigatus was performed as pre-
viously described (Garlanda et al., 2002) at different pHs.
Surface plasmon resonance
The ProteOn XPR36 Protein Interaction Array system (Bio-Rad Laborato-
ries), based on surface plasmon resonance (SPR) technology, was used for bind-
ing studies. Plg was immobilized onto one cell surface of a ProteOn GLC 
sensor chip (Bio-Rad Laboratories), using amine-coupling chemistry. In brief, the 
surface was activated for 5 min with a mixture of EDC (0.2 M) and sulfo-NHS 
(0.05 M), and then Plg was diluted to 30 µg/ml in acetate buffer pH 5.0 and 
flowed for 5 min at a rate of 30 µl/min. The remaining activated groups 
were blocked with a 5-min injection of 1 M ethanolamine. The immobiliza-
tion level was 6,500–7,000 resonance units (RU; 1 RU = 1 pg protein/
mm2). Full-length PTX3, its C and N domain were injected over immobi-
lized Plg at a rate of 30 µl/min for 10 min (association phase). To exclude 
mass transport artifacts, the experiment was also performed changing the flow 
rate to 100 µl/min. Dissociation phase was measured in the following 15 min. 
The analyte running buffer was PBS2+ at pH 6.0 or pH 7.4, containing 150 
mM NaCl and 0.005% (vol/vol) Tween 20. Alternatively, PTX3 and its do-
mains were covalently immobilized as previously described (Deban et al., 
2010). In brief, after the activation step, the different ligands were diluted to a 
final concentration of 30 µg/ml in acetate buffer (pH 2.5–3.0 for PTX3 and N 
domain PTX3; 4.0 for C domain PTX3). The amounts of PTX3 and C and 
N domain of PTX3 covalently immobilized onto the surface were 3,000, 
1,000, and 2,000 RU, respectively. After 90 degree rotation of the fluidic 
system, Plg was diluted in running buffer (PBS2+ pH 6.0) and injected over 
immobilized ligands at a rate of 30 µl/min, for 5 min (association phase), whereas 
dissociation was followed for 10 min. The sensorgrams (time course of the 
SPR signal in RU) were normalized to a baseline value of 0. The resulting 
sensorgrams were fitted using the simplest 1:1 interaction model (Langmuir 
model; ProteOn analysis software) to obtain the corresponding association 
and dissociation rate constants (Kon and Koff). To determine the affinity of a 
single molecule of Plg to a single binding site of PTX3, the experiment 
was also performed flowing Plg (monomeric) onto immobilized PTX3 (oc-
tameric) and the N domain (tetramer; Inforzato et al., 2010). Binding con-
stants were calculated considering PTX3 as an octamer, the N domain as a 
tetramer, and the C domain as a monomer (Inforzato et al., 2010).
Collagen
The collagen content of damaged liver and lung was measured with a conven-
tional OHpro method (Tager et al., 2004). In brief, organs were homogenized 
in 1 ml of PBS2+, and a 0.5 ml aliquot was hydrolyzed in 6 N HCl at 110°C 
for 12 h. 25-µl aliquots were added to 0.5 ml of 1.4% chloramine T (Sigma-
Aldrich), 10% n-propanol, and 0.5 M sodium acetate. After 20 min of incubation 
at room temperature, 0.5 ml of Erlich’s solution (1 M p-dimethylaminobenzal-
dehyde [Sigma-Aldrich] in 70% n-propanol, 20% perchloric acid) was added 
and a 15-min incubation at 65°C was performed. Absorbance was measured at 
550 nm and the amount of OH-pro was determined against a standard curve. 
Sirius red staining is described in the Histology section.
previously described (Mitchell et al., 2009). For acute studies, animals were 
injected once with CCl4 and euthanized after 8, 24, and 48 h. For chronic stud-
ies, animals were treated twice a week for 6 wk and sacrificed 2 and 10 d 
after the last CCl4 injection, respectively, for fibrosis and fibrosis resolution 
quantification. Livers were then perfused by flushing 5 ml PBS2+, excised, 
and embedded in paraffin for histological analysis or frozen in OCT com-
pound at 80°C for confocal microscopy analysis.
Lung injury. Acid-induced acute lung injury was performed as previously 
described (Deban et al., 2010). Lungs were sampled to analyze fibrin deposi-
tion and collagen content, 1 and 4 weeks after damage, respectively.
Arterial thrombosis. Experimental arterial thrombosis was induced as pre-
viously described (Barbieri et al., 2012). In brief, mice (8–12 wk old, C57BL/6J) 
were anesthetized with ketamine chlorydrate (75 mg/kg) and medetomidine 
(1 mg/kg; Virbic). The left carotid artery was dissected free and placed in the 
probe (model 0.7V; Transonic System) connected to transonic flow meter 
(Transonic T106). After blood flow stabilization (baseline flow constant for 
7 min), filter paper imbibed with FeCl3 (10-20%) was applied downstream of 
the probe to the top of the exposed carotid. After 3 minutes, the filter paper 
was removed, the carotid artery was washed with PBS, and the flow was re-
corded for 30 minutes.
RNA and protein
Real-time PCR experiments were performed using the SybrGreen PCR 
Master Mix (Applied Biosystems) in a 7900HT fast real-time PCRsystem 
(Applied Biosystems) in accordance to the manufacturer’s instructions (Applied 
Biosystems) and the following primers: Ptx3, 5-ATTGCTGTTTCACAA-
CCTGC-3, 5-CGCTGTGCTGGAGGAACT-3; or 5-ACGAAATAG-
ACAATGGACTTC-3, 5-AGTCGCATGGCGTGGG-3 (for sorted cells); 
TF, 5-CCGACGAGATTGTGAAGGATGT-3, 5-AGAGGCTCCCC-
AGCAGAAC-3. Data were normalized by -actin or GAPDH expression, 
analyzed with the 2CT method, and expressed as fold change in respect to 
unwounded skin or absolute values for isolated cells.
Whole wounds were collected at 1, 2, and 7 d after wounding and ho-
mogenized in 50 mM Tris-HCl, pH 7.5, containing 2 mM EGTA, 1 mM 
PMSF, 100 KU Aprotinin, 1% Triton X-100 (all from Sigma-Aldrich), and 
complete protease inhibitor cocktail (Roche). Total proteins were measured 
by DC Protein Assay, according to manufacturer’s instructions (Bio-Rad 
Laboratories). Mouse PTX3 was measured by ELISA based on the monoclo-
nal antibodies MnmE1 (IgG1) and MnmE2 (IgG1), which were obtained 
by immunization of Ptx3/ mice. D-dimer (AMS Biotechnology), PDGF 
(Bio-Medical Assay Co.), 5-HT (LDN Labor Diagnostika Nord), TGF, 
CD62P, CXCL1, CXCL2, and myeloperoxidase (MPO; R&D Systems) were 
measured by ELISA in accordance with the manufacturer’s instructions. West-
ern blot analysis for Plg/plasmin and Factor II/Thrombin was performed 
after loading 50 or 20 µg of wound protein extracts on SDS-PAGE (10% 
acrylamide). The goat polyclonal anti-Plg Kringle 5 (0.5 µg/ml; R&D Sys-
tems) and anti-Factor II/thrombin (0.2 µg/ml; R&D Systems) were used. 
The monoclonal anti-vinculin (0.2 µg/ml; hVIN-1; Sigma-Aldrich) was used 
as loading control. Plg, plasmin, thrombin, or fibrin bands were quantified by 
Fiji-ImageJ (ImageJ; NIH) as a ratio of mean gray intensity values of each pro-
tein relative to vinculin bands, or as absolute values.
Microtiter binding assay
Binding assays were performed as previously described (Sahni and Francis, 
2000; Jeannin et al., 2005). In brief, 96-well plates (Nunc) were coated over-
night with 100 ng/50 µl of purified FG, Glu-Plg, Plg fragments, Factor II/
Thrombin, Factor III, Factor VII, Factor XIV, V3, Annexin II, PAI-1, or 
OmpA diluted in PBS2+ (containing 130 mg/l CaCl2 and 100 mg/l MgCl2; 
Lonza). For fibrin-coated wells, 1 U/ml of thrombin (Sigma-Aldrich) was 
added to 1 mg/ml FG diluted in PBS2+. The solution was mixed, rapidly poured 
in 96-well plates and, after 45 s, before polymerization, aspirated, leaving a 
thin film of fibrin coating on the surface. Nonspecific binding to the plates 
was blocked by incubation for 2 h at 25°C with 0.5% dry milk in PBS2+ 
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Ly6C FITCTM (#AL-21; BD), anti–mouse F4/80 PE/Cy7TM (#BM8; BioLeg-
end), anti–mouse CD3 PerCP-Cy5.5TM (#BM8; BD), anti–mouse CD140A 
(PDGFR) BV421 (#APA5; BD), anti–mouse CD31 PerCP-CyTM5.5 (#MEC 
13.3; BD), rabbit anti-FAP Pacific Orange (AbCam), anti–mouse -SMA 
FITC (#1A4; Sigma-Aldrich), goat anti–mouse PTX3 Alexa Fluor 647 (R&D 
Systems), and isotype-matched control antibodies. Cells were fixed with 2% 
PFA in PBS for 10 min, and when indicated permeabilized with BD Cyto-
fix/Cytoperm kit (BD) according with manufacturer’s instructions. Cells 
viability before the fixation and permeabilization was determined with LIVE/
DEAD Fixable Aqua Dead Cell Stain kit (Molecular Probes). Flow cytometry 
was performed using BD LSRFortessa instrument and BD FACSDiva Ver-
sion 8.0.1 software (BD). Cell sorting was conducted using BD FACSAria III 
system. The purity of isolated cells was ≥ 98%.
Confocal and two-photon microscopy
5-µm cryostat sections were incubated in 5% of normal goat (Dako) or donkey 
(Sigma-Aldrich) serum, 2% BSA, 0.1% Triton X-100 (Sigma-Aldrich) in PBS2+, 
pH 7.4, (blocking buffer) for 1 h at room temperature. Sections were incubated 
with the following primary antibodies for 2 h at room temperature: affinity-
purified rabbit polyclonal IgG anti-PTX3 (1 µg/ml) or affinity purified goat 
IgG anti-PTX3/TSG-14 (2 µg/ml; R&D Systems); rat monoclonal (IgG2, 
2 µg/ml; Cell Sciences) or rabbit polyclonal (prediluted; AbCam) anti-PDGFR; 
rat monoclonal anti–mouse CD68 (IgG2a, 1 µg/ml; Hycult Biotech); goat poly-
clonal anti-uPAR (5 µg/ml; AbCam); goat polyclonal anti-uPA (2 µg/ml; R&D 
Systems); rabbit polyclonal anti-fibrin(ogen) (5 µg/ml; Dako); rat monoclo-
nal anti-Plg (IgG1, 5 µg/ml; Cell Sciences); rabbit polyclonal anti-collagen I 
(4 µg/ml; AbCam); mouse monoclonal anti–-SMA (2 µg/ml; Sigma-Aldrich); 
goat anti-proteinase activated receptor-1 (PAR1; 1 µg/ml; R&D Systems); rab-
bit anti-fibroblast activation protein (FAP; 5 µg/ml; AbCam); rat anti-CD45 al-
lophycocyanin (APC; BD); and rat anti-Ly6C FITC (BD). Sections were then 
incubated for 1 h with Alexa Fluor (488, 594, 647)–conjugated species-specific 
cross-adsorbed detection antibodies (Molecular Probes). For DNA detection, 
DAPI (300 nM; Invitrogen) was used. After each step, sections were washed with 
PBS2+, pH 7.4, containing 0.01% (vol/vol) Tween 20 (washing buffer). Tissues 
from Ptx3/ mice were used as negative control for PTX3 immunostaining. 
Sections were mounted with the antifade medium FluorPreserve Reagent 
(EMD Millipore) and analyzed with an Olympus Fluoview FV1000 laser scan-
ning confocal microscope with 10× (N.A. 0.4) or oil immersion lens 40× (N.A. 
1.3). Immunoreactivity of -SMA, FAP, PAR1, CD45, Ly6C, collagen I, and 
fibrin in the wounded skin was evaluated as mean ± SD of the intensity grayscale 
levels of confocal images (1024 × 1024) obtained with 10×, 20×, or 40× lens, 
analyzing the whole field of view by FV10-ASW software (version 4.1a; Olym-
pus). For fibrin, 2–5 10× and for Plg, 2–5 40× images/mouse were acquired. 
Colocalization analysis was performed on confocal images acquired with oil 
immersion PLAPO 60× lens (N.A. 1.35) at resolution of 1 AU. Overlay RGB 
images (1024 × 1024; 4–6 images from 5 wounded skins) were imported 
to Imaris software assembled and colocalization was evaluated by Coloc module 
by Imaris (Bitplane AG). In all images, the same threshold fluorescence intensity 
for each channel was fixed, a binary mask of mask colocalization was created and 
the percentage of colocalization material and the Pearson’s index of linear cor-
relation were analyzed. MEF fibrin cultures were fixed in 4% paraformaldehyde, 
and incubated with polyclonal antibodies anti-fibrin(ogen) and PTX3 and 
fluorophore-linked secondary antibodies (Invitrogen). Specimens were analyzed 
with an Olympus Fluoview FV1000 laser scanning confocal microscope in a 
channel mode with 405, 488, 559, and 635 nm excitations. The resulting fluor-
escence emissions were collected using a 425–475 nm (for DAPI), 500–545 nm 
(for Alexa Fluor 488), 595–620nm (for Alexa Fluor 594), and 655–755 nm (for 
Alexa Fluor 647) band-pass filters. Samples were imaged with oil immersion 
lens 60× (N. A. 1.35) in xy optical sections (800 × 800 pixels) of 0.75 µm. For 
fibrin cultures, the z-stacks were acquired at a resolution of 1 AU to allow three-
dimensional reconstruction and presented as three-dimensional projections 
by Imaris software (X64, version 7.2.1; Bitplane AG).
For ex vivo imaging experiments of pH quantification in the skin, 
2-Photon microscopy and the pH-sensitive fluorescent probe 2’, 7’-bis-
(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF; Molecular Probes) 
In vitro fibrinolysis models
For cell-free studies, as previously described (Hiraoka et al., 1998), fibrin gels 
(50 µg each) previously prepared by mixing FG (1 mg/ml) and thrombin 
(1 U/ml), were incubated in 50 mM Tris, 0.01% (vol/vol) Tween 20, pH 6.0, 
with the following purified proteins, and combinations thereof: Plg (1 µg/100 µl), 
uPA (1 ng/100 µl), tPA (1 ng/100 µl), and PTX3 (100 ng/100 µl). After a 16-h 
incubation at 37°C, fibrin gels were suspended in reducing buffer and proteoly-
sis was assessed in 2 µl of sample by Western blot (see below).
For pericellular fibrinolysis studies, WT and Ptx3/ peritoneal macro-
phages and mouse embryonic fibroblasts (MEF) were embedded in fibrin 
gels (3 × 103/ml) as previously described (Carmeliet et al., 1994; Hiraoka 
et al., 1998). In brief, cells were dissociated with trypsin and centrifuged at 
1,000 rpm for 5 min and cell pellet resuspended in a mixture of 2.5 mg/ml 
of Plg-free FG. Thrombin (1 U/ml) was then added and the suspension was 
immediately poured into a 24-multiwell plate (300 µl/well) on rounded glasses. 
The plate was incubated for 30 min at 37°C to allow fibrin polymerization. 
After washing with PBS2+, fibrin cultures were incubated with 1 ml/well of 
complete RPMI 1640 in triplicate at 37°C. Cell fibrinolytic activity was evalu-
ated by quantifying fibrinolysis-derived products released in the medium by 
ELISA, Western blot and by microscopy (see Confocal and two-photon mi-
croscopy section). In brief, 96-well plates were coated overnight with the 
supernatants diluted 1:104 in PBS2+. Nonspecific binding was blocked by in-
cubation for 2 h at 25°C with 0.5% dry milk in PBS2+ before incubation 
(1 h at 25°C) with 100 µl of a purified rabbit polyclonal antibody anti-fibrin 
(ogen) (500 ng/ml; Dako or EMD Millipore) followed by horseradish perox-
idase-linked secondary antibody (GE Healthcare) and TMB substrate (Sigma-
Aldrich). Values are expressed as mean O.D. ± SD of triplicates. Soluble 
fibrinolysis products (3 µl of each sample) were also resolved under reducing 
conditions on 4–12% SDS-PAGE Criterion XT Precast gels (Bio-Rad Lab-
oratories) and detected with polyclonal antibodies anti-fibrin(ogen).
Histology and assessment of tissue sections
For histological analysis, 5-µm-thick paraffin-embedded skin, liver and ca-
rotid artery sections were stained with hematoxylin and eosin (H&E) and 
with Sirius red. Specimens were imaged with an Olympus BX51 microscope 
equipped with a 2× (N. A. 0.06), 4× (N. A. 0.10), 20× (N. A. 0.4) objectives 
and with an Olympus XC50 camera. The thickness of wounded skin clot 
and scab, epithelial gap segment and necroinflammatory area of injured livers 
were measured in different regions of interest of each single image as seg-
ments or free-hand area drawing and quantified using ImageJ (NIH). Count 
of recruited cells was performed in 3–5 fields (0.05 mm2) per section. An 
Olympus dotSlide BX virtual slide scanner equipped with a 10× N.A. 0.25 
objective and with a Peltier cooled camera (1376 × 1032 pixels) was used to 
acquire the entire injured liver specimens. The OlyVIA (version 3.5; Olym-
pus) image software was used to count occluded central veins in the entire 
section. For quantitative analysis of Sirius red-stained collagen and -smooth 
muscle actin; (-SMA) in skin and liver, 2–10 serial images from 3–10 mice 
per group were digitally captured at 100× magnification. Collagen staining, 
-SMA+ and fibrin in lung and liver immunoreactive areas were measured 
using the computer-assisted digital image processing software Image-Pro Plus 
(version 7.0; MediaCybernetics). The total stained area was automatically 
selected on the basis of RGB color segmentation and results are expressed as 
mean percentage of the immunoreactive area ± SD.
Flow cytometry
A single-cell suspension of wounded skin was generated by cutting samples 
into small pieces and digestion in PBS (pH 7.4) supplemented with collage-
nase type I (1 mg/ml; Sigma-Aldrich) and hyaluronidase (125 U/ml; Sigma-
Aldrich) at 37°C for 1 h twice. Finally, a single-cell suspension was obtained 
by mechanical separation followed by 100 µm filtration and erythrocytes 
lysis (0.15 M NH4Cl, 10 nM KHCO3, 1 nM Na4EDTA, pH 7.2). The fol-
lowing fluorophore-conjugated antibodies were used for immunophenotyp-
ing and intracellular staining: anti–mouse CD45 BV605TM (#30-F11; BD) or 
anti–mouse CD45 BV650 (#A20; BioLegend), anti–mouse CD11b BV421 
(#M1/70; BioLegend), anti–mouse Ly6G PE-CF594TM (#1A8; BD), anti–mouse 
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repair, and Fig. S2 showing the method used to measure the pH in wounded 
skin by two-photon microscopy. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20141268/DC1.
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 Figure S1. Gating strategy used in fl ow cytometry analysis for immunophenotyping and sorting leukocytes and stromal cells in the course of 
skin repair 
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 Figure S2. Method used to measure the pH in wounded skin by two-photon microscopy.  (A) Regions of analysis of unwounded or wounded skin 
included in the dotted line. (B, top) BCECF (free acid; 80 μM) fl uorescence intensity images of unwounded and wounded skin areas at different depth 
(from 0 to 20 μm). The decrease in mean fl uorescence intensity measured in the wounded skin area suggests a more protonated confi guration of BCECF 
(HBCECF), and hence a more acidic environment compared to the unwounded skin. Care was taken in checking that autofl uorescence and Second Har-
monic Generation (SHG) signal were lower (8–10 fold) than BCECF signal. (middle) Lifetime fi ts measured in unwounded and wounded regions as a func-
tion of depth. An off-peak time gate was set to reduce the contribution from SHG. (bottom) pH maps, calculated as a fraction of contributions from 
lifetime of HBCECF and unprotonated BCECF (BCECF2), which show the more acidic regions measured in wounded area of the skin. (C) Lifetime distribu-
tion as taken from B (middle). Lines refer to mean lifetimes calculated with Gaussian fi ts of the distributions. (D) pH distribution as taken from B (bottom). 
Lines refer to average pH calculated with Gaussian fi ts. Gray area refers to range of pH considering the mean ±  in the derma (10-20 μm). Data show 
results of one representative mouse out of 5 analyzed.
